Liquidia Technologies Financials
| LQDA Stock | USD 11.62 0.20 1.75% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.88 | 4.8463 |
|
|
The financial analysis of Liquidia Technologies is a critical element in measuring its lifeblood. Investors should not minimize Liquidia Technologies' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Liquidia | Select Account or Indicator |
Understanding current and past Liquidia Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Liquidia Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Liquidia Technologies' assets may result in an increase in income on the income statement.
Please note, the presentation of Liquidia Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Liquidia Technologies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Liquidia Technologies' management manipulating its earnings.
Liquidia Technologies Stock Summary
Liquidia Technologies competes with Biomarin Pharmaceutical, Vaxcyte, Legend Biotech, Bio Techne, and United Therapeutics. Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Liquidia Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US53635D2027 |
| CUSIP | 53635D202 |
| Location | North Carolina; U.S.A |
| Business Address | 419 Davis Drive, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.liquidia.com |
| Phone | 919 328 4400 |
| Currency | USD - US Dollar |
Liquidia Technologies Key Financial Ratios
| Return On Equity | -1.82 | ||||
| Operating Margin | (7.43) % | ||||
| Price To Sales | 66.24 X | ||||
| Revenue | 17.49 M | ||||
| Gross Profit | 13.08 M |
Liquidia Technologies Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 68.8M | 99.5M | 93.7M | 129.2M | 118.3M | 80.1M | |
| Other Current Liab | 6.0M | 6.4M | 5.2M | 4.4M | 14.9M | 15.6M | |
| Net Tangible Assets | 34.9M | 61.6M | 57.0M | 82.8M | 95.2M | 100.0M | |
| Net Debt | (31.4M) | (48.2M) | (41.4M) | (68.8M) | (80.2M) | (76.2M) | |
| Retained Earnings | (215.2M) | (275.0M) | (309.6M) | (350.6M) | (429.1M) | (407.6M) | |
| Accounts Payable | 3.5M | 3.7M | 1.1M | 2.2M | 1.4M | 2.2M | |
| Cash | 55.8M | 65.3M | 57.5M | 93.3M | 83.7M | 55.0M | |
| Other Assets | 378.0K | 17.2M | 16.7M | 129.2M | 1.0 | 0.95 | |
| Long Term Debt | 10.3M | 10.3M | 10.4M | 19.9M | 22.9M | 11.5M | |
| Other Current Assets | 590.3K | 752.4K | 792.4K | 1.5M | 2.2M | 2.3M | |
| Total Liab | 33.9M | 28.4M | 28.5M | 38.8M | 71.0M | 42.2M | |
| Total Current Assets | 56.4M | 66.1M | 61.3M | 99.8M | 89.9M | 58.0M | |
| Short Term Debt | 7.4M | 1.6M | 1.1M | 2.2M | 2.3M | 3.5M | |
| Common Stock | 28.2K | 43.3K | 52.3K | 64K | 69K | 37.6K | |
| Net Invested Capital | 50.8M | 81.4M | 75.7M | 110.3M | 47.3M | 60.3M | |
| Net Working Capital | 39.5M | 54.3M | 53.9M | 91.0M | 71.3M | 49.8M | |
| Capital Stock | 28.2K | 43.3K | 52.3K | 64K | 69K | 49.9K |
Liquidia Technologies Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | (759.9K) | (673.6K) | (781.6K) | (1.2M) | (1.8M) | (1.9M) | |
| Interest Income | 613.7K | 184.4K | 33.4K | 1.1M | 3.2M | 3.3M | |
| Interest Expense | 1.4M | 858.0K | 815.0K | 2.3M | 6.3M | 4.4M | |
| Total Revenue | 8.1M | 739.6K | 12.9M | 15.9M | 17.5M | 10.8M | |
| Gross Profit | 7.3M | 501.9K | 9.8M | 13.1M | 14.6M | 9.2M | |
| Operating Income | (46.8M) | (59.1M) | (33.8M) | (38.8M) | (73.4M) | (69.7M) | |
| Ebit | (46.8M) | (58.9M) | (33.8M) | (38.7M) | (72.2M) | (68.6M) | |
| Research Development | 40.5M | 32.2M | 20.5M | 19.4M | 43.2M | 32.0M | |
| Ebitda | (46.2M) | (55.8M) | (27.9M) | (34.7M) | (70.1M) | (66.5M) | |
| Cost Of Revenue | 807.2K | 237.7K | 3.0M | 2.9M | 2.9M | 1.5M | |
| Income Before Tax | (47.6M) | (59.8M) | (34.6M) | (41.0M) | (78.5M) | (74.6M) | |
| Net Income | (46.4M) | (57.5M) | (29.8M) | (38.4M) | (78.5M) | (74.6M) | |
| Income Tax Expense | (1.2M) | (2.3M) | (4.8M) | (2.7M) | (2.2M) | (2.1M) |
Liquidia Technologies Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (1.9M) | 247.9K | (107.2K) | (587K) | (11.6M) | (11.0M) | |
| Change In Cash | 16.3M | 9.5M | (7.8M) | 35.8M | (9.6M) | (9.1M) | |
| Net Borrowings | 4.0M | (6.8M) | (419.8K) | 9.0M | 8.1M | 4.6M | |
| Free Cash Flow | (50.1M) | (54.9M) | (34.1M) | (29.2M) | (42.9M) | (45.0M) | |
| Depreciation | 2.6M | 3.1M | 5.6M | 3.6M | 2.2M | 2.8M | |
| Other Non Cash Items | 300.9K | 235.5K | 522.3K | 1.6M | 18.8M | 19.7M | |
| Capital Expenditures | 1.9M | 752.1K | 107.2K | 592K | 1.3M | 1.1M | |
| Net Income | (47.6M) | (59.8M) | (34.6M) | (41.0M) | (78.5M) | (74.6M) | |
| End Period Cash Flow | 55.8M | 65.3M | 57.5M | 93.3M | 83.7M | 55.0M | |
| Change To Netincome | 3.4M | 4.1M | 7.3M | 10.9M | 12.6M | 13.2M |
Liquidia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Liquidia Technologies's current stock value. Our valuation model uses many indicators to compare Liquidia Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Liquidia Technologies competition to find correlations between indicators driving Liquidia Technologies's intrinsic value. More Info.Liquidia Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Liquidia Technologies' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Liquidia Technologies' earnings, one of the primary drivers of an investment's value.Liquidia Technologies Systematic Risk
Liquidia Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Liquidia Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Liquidia Technologies correlated with the market. If Beta is less than 0 Liquidia Technologies generally moves in the opposite direction as compared to the market. If Liquidia Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Liquidia Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Liquidia Technologies is generally in the same direction as the market. If Beta > 1 Liquidia Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Liquidia Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Liquidia Technologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Liquidia Technologies growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Liquidia Technologies November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Liquidia Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Liquidia Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Liquidia Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Liquidia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Liquidia Technologies's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.11 | |||
| Information Ratio | 0.0662 | |||
| Maximum Drawdown | 18.78 | |||
| Value At Risk | (3.39) | |||
| Potential Upside | 4.93 |
Complementary Tools for Liquidia Stock analysis
When running Liquidia Technologies' price analysis, check to measure Liquidia Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Liquidia Technologies is operating at the current time. Most of Liquidia Technologies' value examination focuses on studying past and present price action to predict the probability of Liquidia Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Liquidia Technologies' price. Additionally, you may evaluate how the addition of Liquidia Technologies to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |